Cystic fibrosis and COVID-19: Care considerations
Fecha
2020Autor
Mirza, Alicia A.
Rad, Elika J.
Mohabir, Paul K.
Documentos PDF
Resumen
The coronavirus disease 2019 (COVID-19) pandemic has demanded large scale changes in
patient care. People with cystic fibrosis have unique considerations, including underlying lung
disease and routine aerosolizing therapies, but there is insufficient evidence to create
comprehensive practice guidelines. We share a case of a patient with CF and COVID-19 as well
as alterations to routine CF care at a large academic center. Key considerations include
accessible COVID-19 screening, augmented infection control practices, and rapid integration of
telemedicine.
Palabras clave
Cystic fibrosis; Pulmonary; Covid-19; Infection controlEnlace al recurso
https://doi.org/10.1016/j.rmcr.2020.101226Colecciones
Estadísticas Google Analytics
Comentarios
Respuesta Comentario Repositorio Expeditio
Gracias por tomarse el tiempo para darnos su opinión.